Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-09-007152
Filing Date
2009-08-04
Accepted
2009-08-04 06:15:58
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2193908z10-q.htm 10-Q 494521
2 EXHIBIT 10.1 a2193908zex-10_1.htm EX-10.1 47995
3 EXHIBIT 10.2 a2193908zex-10_2.htm EX-10.2 39842
4 EXHIBIT 10.3 a2193908zex-10_3.htm EX-10.3 7306
5 EX-31.1 a2193908zex-31_1.htm EX-31.1 7528
6 EX-31.2 a2193908zex-31_2.htm EX-31.2 7576
7 EX-32.1 a2193908zex-32_1.htm EX-32.1 4496
  Complete submission text file 0001047469-09-007152.txt   610493
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 09981604
SIC: 2834 Pharmaceutical Preparations